CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berezutskaya, E.
Right arrow Articles by Bagchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berezutskaya, E.
Right arrow Articles by Bagchi, S.

Cell Growth & Differentiation, Vol 8, Issue 12 1277-1286, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein

E Berezutskaya, B Yu, A Morozov, P Raychaudhuri and S Bagchi
Center for Molecular Biology of Oral Diseases, College of Dentistry 60612, USA.

The human papillomavirus E7 oncoprotein binds to the retinoblastoma (Rb) tumor suppressor protein, and the binding to Rb correlates with the oncogenic potential of E7. Recent studies from several laboratories indicated that the half-life of the Rb protein is reduced in cells that are stably transformed with E7, suggesting that E7 could induce the proteolytic degradation of Rb. To investigate whether the Rb degradation is a primary effect of E7 or a result of altered cell phenotype, we sought to develop assays that can distinguish between the two possibilities. Using recombinant adenovirus expressing the human papillomavirus type 16 E7 protein, we show that the expression of E7 leads to an increased rate of decay of the Rb protein. Moreover, Rb degradation immediately follows the expression of E7 suggesting that it is an early and primary effect. Consistent with a previous study, we observed that the E7-induced degradation of Rb can be blocked by the inhibitors of the 26S proteasome. We have also developed a transient transfection assay for the E7-induced degradation of Rb. Using this assay, we show that the pocket domain of Rb is necessary and sufficient for the E7-induced degradation. However, the proteolysis is relatively specific for Rb because the level of p107 or p130 was not significantly altered by the expression of E7. Thus, although E7 binds to all three members of the Rb family of proteins, the proteolysis is much more efficient in the case of Rb. In the transient transfection assays, adenovirus E1A and SV40 large T antigen failed to induce degradation of Rb, suggesting that the Rb degradation is a unique property of the E7 oncoprotein.


This article has been cited by other articles:


Home page
mBioHome page
E. A. White, K. Münger, and P. M. Howley
High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation
mBio, November 2, 2016; 7(5): e01530-16 - e01530-16.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. S. Boon and L. Banks
High-Risk Human Papillomavirus E6 Oncoproteins Interact with 14-3-3{zeta} in a PDZ Binding Motif-Dependent Manner
J. Virol., February 1, 2013; 87(3): 1586 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. White, M. E. Sowa, M. J. A. Tan, S. Jeudy, S. D. Hayes, S. Santha, K. Munger, J. W. Harper, and P. M. Howley
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses
PNAS, January 31, 2012; 109(5): E260 - E267.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. J. Genovese, T. R. Broker, and L. T. Chow
Nonconserved Lysine Residues Attenuate the Biological Function of the Low-Risk Human Papillomavirus E7 Protein
J. Virol., June 1, 2011; 85(11): 5546 - 5554.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Huh, X. Zhou, H. Hayakawa, J.-Y. Cho, T. A. Libermann, J. Jin, J. Wade Harper, and K. Munger
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor
J. Virol., September 15, 2007; 81(18): 9737 - 9747.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K.-J. Oh, A. Kalinina, N.-H. Park, and S. Bagchi
Deregulation of eIF4E: 4E-BP1 in Differentiated Human Papillomavirus-Containing Cells Leads to High Levels of Expression of the E7 Oncoprotein
J. Virol., July 15, 2006; 80(14): 7079 - 7088.
[Abstract] [Full Text] [PDF]


Home page
Clin. Sci.Home page
J. Doorbar
Molecular biology of human papillomavirus infection and cervical cancer
Clin. Sci., May 1, 2006; 110(5): 525 - 541.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Knight, N. Sharma, and E. S. Robertson
Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase
PNAS, December 20, 2005; 102(51): 18562 - 18566.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Munger, A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh
Mechanisms of Human Papillomavirus-Induced Oncogenesis
J. Virol., November 1, 2004; 78(21): 11451 - 11460.
[Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. S. Longworth and L. A. Laimins
Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 362 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K.-J. Oh, A. Kalinina, J. Wang, K. Nakayama, K. I. Nakayama, and S. Bagchi
The Papillomavirus E7 Oncoprotein Is Ubiquitinated by UbcH7 and Cullin 1- and Skp2-Containing E3 Ligase
J. Virol., May 15, 2004; 78(10): 5338 - 5346.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Psyrri, R. A. DeFilippis, A. P. B. Edwards, K. E. Yates, L. Manuelidis, and D. DiMaio
Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells
Cancer Res., May 1, 2004; 64(9): 3079 - 3086.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X. Fan, Y. Liu, and J. J. Chen
Activation of c-Myc Contributes to Bovine Papillomavirus Type 1 E7-induced Cell Proliferation
J. Biol. Chem., October 31, 2003; 278(44): 43163 - 43168.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. F. Kalejta, J. T. Bechtel, and T. Shenk
Human Cytomegalovirus pp71 Stimulates Cell Cycle Progression by Inducing the Proteasome-Dependent Degradation of the Retinoblastoma Family of Tumor Suppressors
Mol. Cell. Biol., March 15, 2003; 23(6): 1885 - 1895.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. von Willebrand, E. Zacksenhaus, E. Cheng, P. Glazer, and R. Halaban
The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells
Cancer Res., March 15, 2003; 63(6): 1420 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A.-M. Helt, J. O. Funk, and D. A. Galloway
Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells
J. Virol., October 15, 2002; 76(20): 10559 - 10568.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. A. Dick and N. J. Dyson
Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins
J. Virol., June 15, 2002; 76(12): 6224 - 6234.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W.-M. Chien, F. Noya, H. M. Benedict-Hamilton, T. R. Broker, and L. T. Chow
Alternative Fates of Keratinocytes Transduced by Human Papillomavirus Type 18 E7 during Squamous Differentiation
J. Virol., March 15, 2002; 76(6): 2964 - 2972.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. G. Hwang, D. Lee, J. Kim, T. Seo, and J. Choe
Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner
J. Biol. Chem., January 25, 2002; 277(4): 2923 - 2930.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. L. Gonzalez, M. Stremlau, X. He, J. R. Basile, and K. Munger
Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7
J. Virol., August 15, 2001; 75(16): 7583 - 7591.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A.-M. Helt and D. A. Galloway
Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes
J. Virol., August 1, 2001; 75(15): 6737 - 6747.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Noya, W.-M. Chien, T. R. Broker, and L. T. Chow
p21cip1 Degradation in Differentiated Keratinocytes Is Abrogated by Costabilization with Cyclin E Induced by Human Papillomavirus E7
J. Virol., July 1, 2001; 75(13): 6121 - 6134.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. C. Goodwin and D. DiMaio
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
PNAS, November 7, 2000; 97(23): 12513 - 12518.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Wu, E. C. Goodwin, L. K. Naeger, E. Vigo, K. Galaktionov, K. Helin, and D. DiMaio
E2F-Rb Complexes Assemble and Inhibit cdc25A Transcription in Cervical Carcinoma Cells following Repression of Human Papillomavirus Oncogene Expression
Mol. Cell. Biol., October 1, 2000; 20(19): 7059 - 7067.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
W.-M. Chien, J. N. Parker, D.-C. Schmidt-Grimminger, T. R. Broker, and L. T. Chow
Casein Kinase II Phosphorylation of the Human Papillomavirus-18 E7 Protein Is Critical for Promoting S-Phase Entry
Cell Growth Differ., August 1, 2000; 11(8): 425 - 435.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. M. Spancake, C. B. Anderson, V. M. Weaver, N. Matsunami, M. J. Bissell, and R. L. White
E7-transduced Human Breast Epithelial Cells Show Partial Differentiation in Three-dimensional Culture
Cancer Res., December 1, 1999; 59(24): 6042 - 6045.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Smith-McCune, D. Kalman, C. Robbins, S. Shivakumar, L. Yuschenkoff, and J. M. Bishop
Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130
PNAS, June 8, 1999; 96(12): 6999 - 7004.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. G. Hwang, D. Lee, J. Kim, T. Seo, and J. Choe
Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner
J. Biol. Chem., January 25, 2002; 277(4): 2923 - 2930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.